Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 71093-139

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 71093-139). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aci Healthcare Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-label-150mg-60c (150mg 60c)

Quetiapine Extended Release Tablets USP 150 mg film-coated extended-release oral tablets. The label indicates a package containing 60 tablets, with the dosage instruction showing one tablet once daily. Manufactured and labeled by ACI Healthcare USA, Inc. The label includes storage instructions, a barcode, and warnings to keep the medication out of reach of children.*

FDA Label Image

Container-label-200mg-60c (200mg 60c)

Label of Quetiapine Extended Release Tablets, USP 200 mg, film-coated, extended release oral tablets. The label indicates a package of 60 tablets with a dosage instruction of once daily. The product is from ACI Healthcare USA, Inc., with an NDC number 71093-137-02. Storage instructions and warnings to keep out of reach of children are also visible.*

FDA Label Image

Container-label-300mg-60c (300mg 60c)

Quetiapine Extended Release 300 mg film-coated tablets, USP, packaged in a bottle containing 60 tablets. The label includes dosage instructions indicating once daily use and cautions not to split, chew, or crush the tablets. Distributed by ACI Healthcare USA, Inc., the label features the NDC 71093-138-02 and highlights storage and safety warnings, including keeping out of reach of children.*

FDA Label Image

Container-label-400mg-60c (400mg 60c)

Quetiapine Extended Release Tablets, USP 400 mg film-coated extended-release oral tablets by ACI Healthcare USA, Inc. The label indicates a 60-count package with dosage instructions mentioning once daily use. The label also includes storage information and cautions to keep out of children's reach.*

FDA Label Image

50mg 60c

Quetiapine Extended Release 50 mg tablet label for oral use, manufactured by ACI Healthcare USA, Inc. It is a film-coated, extended-release tablet with dosing instruction of once daily. The label includes storage instructions, a barcode, NDC 71093-135-02, and a pharmacist dispensing note.*

FDA Label Image

Image 1 (Image 01)

Chemical structure diagram of quetiapine and associated components as shown in the image, corresponding to the active ingredient in Quetiapine Extended Release tablets.*

FDA Label Image

Image Description (Image 02)

A line graph showing the proportion of patients with relapse (%) on the y-axis over time in months on the x-axis, comparing two groups labeled PLA and QTP XR. The graph displays relapse proportions increasing over 7 months, with the PLA group showing a higher relapse proportion than the QTP XR group throughout the period.*

FDA Label Image

Image 3 (Image 03)

A Kaplan-Meier survival curve chart showing the proportion of patients with relapse over time in weeks. Two lines represent different treatment groups labeled as CTP + LIVAL and PLA + LIVAL, illustrating differences in relapse rates across approximately 80 weeks.*

FDA Label Image

Image 4 (Image 04)

A line graph showing the proportion of patients with relapse over time in weeks for two groups labeled QTP + LIVAL and PLA + LIVAL. The y-axis represents the percentage of patients with relapse, and the x-axis represents time in weeks, ranging up to 100 weeks. The graph compares relapse rates between the two groups across the study period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.